Stock Price Quote

MARKSANS PHARMA LTD.

NSE : MARKSANSBSE : 524404ISIN CODE : INE750C01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE17.05-1.25 (-6.83 %)
PREV CLOSE ( ) 18.30
OPEN PRICE ( ) 18.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 102376
TODAY'S LOW / HIGH ( )16.85 18.00
52 WK LOW / HIGH ( )11.45 28.1
NSE17.00-1.35 (-7.36 %)
PREV CLOSE( ) 18.35
OPEN PRICE ( ) 17.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 17.00 (13950)
VOLUME 963037
TODAY'S LOW / HIGH( ) 16.85 17.85
52 WK LOW / HIGH ( )11.4 28.1
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1992
Management Info
Mark Saldanha - Chairman Mark Saldanha - Managing Director
Registered Office

Address 11th Floor, " Grandeur ",Opp. Gundeecha Symphony, Veera Desai Extension Road,Oshiwara, Andheri (W),
Mumbai,
Maharashtra-400053

Phone 022- 40012000

Email companysecretary@marksanspharma.com

Website www.marksanspharma.com

Registrars Details
Bigshare Services Pvt Ltd
Bharat Tin Works Building,1st floor, Opp. Vasant Oasis,Andheri (E),Mumbai
Listing : BSE, NSE

NEWS

11Feb Receipt Of Establishment Inspection R
We are pleased to announce receipt of Establishment Inspection Report (E..
11Feb Marksans Pharma receives EIR from USFD
Marksans Pharma has received Establishment Inspection Report (EIR) from..
11Feb Marksans Pharma shines on receiving EI
Marksans Pharma is currently trading at Rs. 23.10, up by 1.00 points or..
17Jan Intimation With Respect To Redemption
We wish to inform you that the Company has redeemed 200,000 7% Redeemabl..
14Jan Marksans Pharma informs about certific
Marksans Pharma has informed that the Company enclosed a Certificate und..

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit129.75436.17
Gross Profit 161.21 560.11
Operating Profit 202.66712.6
Net Sales 1168.784241.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Pfizer (BSE)
peergroup  4200.45 (1.02%)
M.Cap ( in Cr)19216.11
Procter&Gamble Healt (BSE)
peergroup  4179.90 (0.33%)
M.Cap ( in Cr)6938.38
Ipca Laboratories (BSE)
peergroup  1361.70 (0.80%)
M.Cap ( in Cr)17205.37
Eris Lifesciences (BSE)
peergroup  433.60 (2.48%)
M.Cap ( in Cr)5887.45
Shree Ganesh Remed. (BSE)
peergroup  108.45 (7.80%)
M.Cap ( in Cr)97.29

Shareholding Pattern

NON-INSTITUTION 48.67%
PROMOTERS 48.25%
FI/BANKS/INSURANCE 0.39%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
GS CNX 500(G)0.02

About Marksans Pharma Ltd.

Marksans Pharma Ltd. was incorporated in the year 1992. Its today's share price is 18.3. Its current market capitalisation stands at Rs 697.88 Cr. In the latest quarter, company has reported Gross Sales of Rs. 0 Cr and Total Income of Rs.0 Cr. The company's management includes Abhinna Sundar Mohanty, Digant Mahesh Parikh, Seetharama Raju Buddharaju, Varddhman Vikramaditya Jain, Sandra Saldanha, Mark Saldanha, Mark Saldanha.

It is listed on the BSE with a BSE Code of 524404 , NSE with an NSE Symbol of MARKSANS and ISIN of INE750C01026. It's Registered office is at 11th Floor, " Grandeur ",Opp. Gundeecha Symphony, Veera Desai Extension Road,Oshiwara, Andheri (W)Mumbai-400053, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Bhuta Shah & Co LLP, NK Mittal & Associates, VS Lalpuria & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X